Emerald Mutual Fund Advisers Trust Madrigal Pharmaceuticals, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.45 Billion
- Q4 2024
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 18,656 shares of MDGL stock, worth $6.14 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
18,656
Previous 21,687
13.98%
Holding current value
$6.14 Million
Previous $4.6 Million
25.08%
% of portfolio
0.4%
Previous 0.26%
Shares
7 transactions
Others Institutions Holding MDGL
# of Institutions
335Shares Held
22.3MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$727 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$672 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$668 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$656 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$650 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.63B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...